Mr Harald Fricke
Management Board
Apogenix
Germany
Biography
Harald Fricke, M.D., has been Chief Medical Officer of Apogenix since January 2006. Previously, he was responsible for the global clinical development at Fresenius Biotech GmbH and headed Baxter Oncology's clinical development department for three years. From 1996 to 2001, he held various national and international management positions at SmithKline Beecham and GlaxoSmithKline, respectively. Dr. Fricke obtained his M.D. in 1987 after studying medicine at the University of Aachen and the University of Luebeck in Germany. From 1987 to 1990, he worked as a postdoc at the Weizmann Institute of Science in Israel. Following his accreditation as a specialist in internal medicine in 1993, he received his habilitation in 1996 from Ludwig Maximilians University in Munich, Germany.
Research Interest
business
